ziyad al aly glp 1 Stopping or interrupting GLP-1 usage may trigger “metabolic whiplash,” according to research from Al-Aly, MD. CNN explores the WashU Medicine study, which states that even brief pauses may reduce the drugs' The finding that stopping GLP-1
Description
Circulation 2021

The results further supported the cardiorenal benefits of GLP-1 medicines with or without concomitant use of sodium-glucose co-transporter 2 inhibitors (SGLT2i)
Semaglutide (also injected weekly) was associated with an average weight loss of around 11% after 24 to 68 weeks, with evidence suggesting the effect can persist for up to two years, based on 18 randomized controlled trials (27 949 participants)

MariTide combines GLP-1 receptor agonism with GIP antagonism, a novel approach validated by human genetics research

Wing RR, Phelan S
